Kodikaz is a gene therapy platform company that has the unique technical ability of specifically targeting cancer cells.
Kodikaz Therapeutic Solutions has raised $256K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Kodikaz Therapeutic Solutions's investors include National Science Foundation, Georgia Research Alliance.
Kodikaz Therapeutic Solutions is headquartered in New York, United States.
Kodikaz is a gene therapy platform company that has the unique technical ability of specifically targeting cancer cells.
Kodikaz Therapeutic Solutions is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kodikaz Therapeutic Solutions — Funding & Investors." VCBacked, August 15, 2021, https://www.vcbacked.co/company/kodikaz-therapeutic-solutions. Accessed September 30, 2026.
VCBacked. (2021). Kodikaz Therapeutic Solutions — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/kodikaz-therapeutic-solutions
{{cite web |title=Kodikaz Therapeutic Solutions — Funding & Investors |url=https://www.vcbacked.co/company/kodikaz-therapeutic-solutions |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated